GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Science 37 Holdings Inc (NAS:SNCE) » Definitions » Piotroski F-Score

Science 37 Holdings (Science 37 Holdings) Piotroski F-Score : 3 (As of May. 17, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Science 37 Holdings Piotroski F-Score?

Warning Sign:

Piotroski F-Score of 3 is low, which usually implies poor business operation.

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Science 37 Holdings has an F-score of 3. It is a bad or low score, which usually implies poor business operation.

The historical rank and industry rank for Science 37 Holdings's Piotroski F-Score or its related term are showing as below:

SNCE' s Piotroski F-Score Range Over the Past 10 Years
Min: 2   Med: 3   Max: 3
Current: 3

During the past 3 years, the highest Piotroski F-Score of Science 37 Holdings was 3. The lowest was 2. And the median was 3.


Science 37 Holdings Piotroski F-Score Historical Data

The historical data trend for Science 37 Holdings's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Science 37 Holdings Piotroski F-Score Chart

Science 37 Holdings Annual Data
Trend Jun20 Jun21 Dec22
Piotroski F-Score
N/A N/A 2.00

Science 37 Holdings Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only N/A 2.00 N/A 3.00 3.00

Competitive Comparison of Science 37 Holdings's Piotroski F-Score

For the Health Information Services subindustry, Science 37 Holdings's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Science 37 Holdings's Piotroski F-Score Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Science 37 Holdings's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where Science 37 Holdings's Piotroski F-Score falls into.


How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Sep23) TTM:Last Year (Sep22) TTM:
Net Income was -66.521 + -24.628 + -19.579 + -13.924 = $-124.65 Mil.
Cash Flow from Operations was -15.066 + -19.611 + -13.114 + -0.4 = $-48.19 Mil.
Revenue was 15.937 + 14.086 + 15.351 + 14.887 = $60.26 Mil.
Gross Profit was 3.644 + 2.976 + 5.387 + 5.915 = $17.92 Mil.
Average Total Assets from the begining of this year (Sep22)
to the end of this year (Sep23) was
(189.424 + 126.448 + 101.446 + 86.956 + 75.727) / 5 = $116.0002 Mil.
Total Assets at the begining of this year (Sep22) was $189.42 Mil.
Long-Term Debt & Capital Lease Obligation was $0.05 Mil.
Total Current Assets was $75.54 Mil.
Total Current Liabilities was $18.10 Mil.
Net Income was 0 + 44.894 + -5.833 + -23.528 = $15.53 Mil.

Revenue was 0 + 18.686 + 19.275 + 16.249 = $54.21 Mil.
Gross Profit was 0 + 2.7 + 5.433 + 4.092 = $12.23 Mil.
Average Total Assets from the begining of last year (Sep21)
to the end of last year (Sep22) was
(80.411 + 260.798 + 233.301 + 209.506 + 189.424) / 5 = $194.688 Mil.
Total Assets at the begining of last year (Sep21) was $80.41 Mil.
Long-Term Debt & Capital Lease Obligation was $0.87 Mil.
Total Current Assets was $145.92 Mil.
Total Current Liabilities was $23.09 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Science 37 Holdings's current Net Income (TTM) was -124.65. ==> Negative ==> Score 0.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Science 37 Holdings's current Cash Flow from Operations (TTM) was -48.19. ==> Negative ==> Score 0.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Sep22)
=-124.652/189.424
=-0.65805811

ROA (Last Year)=Net Income/Total Assets (Sep21)
=15.533/80.411
=0.19317009

Science 37 Holdings's return on assets of this year was -0.65805811. Science 37 Holdings's return on assets of last year was 0.19317009. ==> Last year is higher ==> Score 0.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Science 37 Holdings's current Net Income (TTM) was -124.65. Science 37 Holdings's current Cash Flow from Operations (TTM) was -48.19. ==> -48.19 > -124.65 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Sep23)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Sep22 to Sep23
=0.047/116.0002
=0.00040517

Gearing (Last Year: Sep22)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Sep21 to Sep22
=0.873/194.688
=0.0044841

Science 37 Holdings's gearing of this year was 0.00040517. Science 37 Holdings's gearing of last year was 0.0044841. ==> This year is lower or equal to last year. ==> Score 1.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Sep23)=Total Current Assets/Total Current Liabilities
=75.541/18.104
=4.17261379

Current Ratio (Last Year: Sep22)=Total Current Assets/Total Current Liabilities
=145.921/23.088
=6.32020963

Science 37 Holdings's current ratio of this year was 4.17261379. Science 37 Holdings's current ratio of last year was 6.32020963. ==> Last year's current ratio is higher ==> Score 0.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Science 37 Holdings's number of shares in issue this year was 5.907. Science 37 Holdings's number of shares in issue last year was 5.821. ==> There is larger number of shares in issue this year. ==> Score 0.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=17.922/60.261
=0.29740628

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=12.225/54.21
=0.2255119

Science 37 Holdings's gross margin of this year was 0.29740628. Science 37 Holdings's gross margin of last year was 0.2255119. ==> This year's gross margin is higher. ==> Score 1.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Sep22)
=60.261/189.424
=0.31812759

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Sep21)
=54.21/80.411
=0.6741615

Science 37 Holdings's asset turnover of this year was 0.31812759. Science 37 Holdings's asset turnover of last year was 0.6741615. ==> Last year's asset turnover is higher ==> Score 0.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=0+0+0+1+1+0+0+1+0
=3

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Science 37 Holdings has an F-score of 3. It is a bad or low score, which usually implies poor business operation.

Science 37 Holdings  (NAS:SNCE) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Science 37 Holdings Piotroski F-Score Related Terms

Thank you for viewing the detailed overview of Science 37 Holdings's Piotroski F-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Science 37 Holdings (Science 37 Holdings) Business Description

Traded in Other Exchanges
N/A
Address
800 Park Offices Drive, Suite 3606, Research Triangle Park, Durham, NC, USA, 27709
Science 37 Holdings Inc is engaged in the development of new and innovative treatments that impact patient lives. It enables universal access to patients and providers for clinical trials. Its Operating System is fused with networks of telemedicine investigators, mobile nurses, remote coordinators, patient communities and connected devices.
Executives
Troy Bryenton officer: Chief Technology Officer 800 PARK OFFICES DRIVE, SUITE 3606, RESEARCH TRIANGLE PARK NC 27709
Christine A Pellizzari officer: Chief Legal Officer 10 FINDERNE AVENUE, BRIDGEWATER NJ 08807
Autenried Paul Von director BRISTOL-MYERS SQUIBB COMPANY, 100 NASSAU PARK BOULEVARD, PRINCETON NJ 08543
Michael Shipton officer: Chief Commercial Officer 800 PARK OFFICES DRIVE SUITE 3606, RESEARCH TRIANGLE PARK NC 27709
Adam Goulburn director C/O LIFESCI ACQUISITION II CORP., 250 W 55TH STREET, #3401, NEW YORK NY 10019
Thermo Fisher Scientific Powder Us Holdings Corp. 10 percent owner 168 THIRD AVENUE, WALTHAM MA 02451
Thermo Fisher Scientific Inc. 10 percent owner 168 THIRD AVENUE, WALTHAM MA 02451
Neil Tiwari director C/O LIFESCI ACQUISITION II CORP., 250 W 55TH STREET, #3401, NEW YORK NY 10019
Darcy Forman officer: Chief Delivery Officer C/O LIFESCI ACQUISITION II CORP., 250 W 55TH STREET, #3401, NEW YORK NY 10019
David Coman director, officer: Chief Executive Officer C/O LIFESCI ACQUISITION II CORP., 250 W 55TH STREET, #3401, NEW YORK NY 10019
Jonathan Cotliar officer: Chief Medical Officer C/O LIFESCI ACQUISITION II CORP., 250 W 55TH STREET, #3401, NEW YORK NY 10019
Steven Geffon officer: Chief Commercial Officer C/O LIFESCI ACQUISITION II CORP., 250 W 55TH STREET, #3401, NEW YORK NY 10019
De Silva Bhooshitha B. director PPD, INC., 929 NORTH FRONT STREET, WILMINGTON NC 28401
Mike Zaranek officer: Chief Financial Officer C/O LIFESCI ACQUISITION II CORP., 250 W 55TH STREET, #3401, NEW YORK NY 10019
Ppd, Inc. 10 percent owner 929 NORTH FRONT STREET, WILMINGTON NC 28401-3331